B. Riley Securities Maintains Buy on Oncology Institute, Raises Price Target to $8

Benzinga Newsdesk www.benzinga.com Positive 82.1%

Neg 0% Neu 0% Pos 82.1%

B. Riley Securities analyst Yuan Zhi maintains Oncology Institute (NASDAQ:TOI) with a Buy and raises the price target from $6 to $8.